Smruthi Organics Limited (BOM:540686)
India flag India · Delayed Price · Currency is INR
122.65
-3.70 (-2.93%)
At close: Mar 6, 2026

Smruthi Organics Company Description

Smruthi Organics Limited manufactures and markets active pharmaceutical ingredient (API) products to India.

The company provides API for cardiovascular that includes amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan; for anti diabetic, which comprises metformin HCL, vildagliptin, teneligliptin, and dapagliflozin; and for anti infectives that consists of ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate, as well as ticagrelor for anti platelets.

It also offers drug intermediates, such as amlodipine base, s-amlodipine base, and phthaloyl amlodipine.

In addition, the company is developing empagliflozin for anti-diabetics; and apixaban and rivaroxaban for anti-platelets.

It also exports its products. The company was incorporated in 1989 and is headquartered in Solapur, India.

Smruthi Organics Limited
Country India
Founded 1989
Industry Medicinal Chemicals and Botanical Products
Employees 267
CEO Purushotham Eaga

Contact Details

Address:
165-A, Balaji Bhavan
Solapur, Maharashtra 413001
India
Phone 91 21 7231 0267
Website smruthiorganics.com

Stock Details

Ticker Symbol 540686
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2833

Key Executives

Name Position
Purushotham Eaga Chief Executive Officer
Swapnil Eaga Chief Financial Officer